You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Castrate-Resistant Prostate Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T Injection
  • (no location specified)
Nov 10, 2023

Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Trial (TmPSMA-02 CAR T Cells)

Not yet recruiting
  • Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
  • TmPSMA-02 CAR T Cells
  • (no location specified)
Sep 13, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 23, 2023

Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)

Not yet recruiting
  • Metastasis Castration Resistant Prostate Cancer(mCRPC)
  • (no location specified)
Aug 14, 2023

Prostatic Tumors, Castration-Resistant Trial (64Cu-SAR-BBN, 67Cu-SAR-BBN)

Not yet recruiting
  • Prostatic Neoplasms
  • Castration-Resistant
  • (no location specified)
Dec 1, 2022

Metastatic Castrate-resistant Prostate Cancer, mCRPC Trial in Dallas (Sipuleucel-T, Stereotactic Ablative Body Radiation)

Completed
Has Results
  • Metastatic Castrate-resistant Prostate Cancer
  • mCRPC
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Apr 11, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
    University of California, San Francisco
Sep 8, 2022

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Carcinoma Trial in

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 19, 2023

Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore

Recruiting
  • Prostate Cancer
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Hospital
May 6, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,

Active, not recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Detroit, Michigan
  • +1 more
Aug 30, 2022

Drug-drug Interactions in Patients Treated With Anticancer

Recruiting
  • Prostatic Neoplasm
  • data collection
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
Nov 9, 2022

Prostate Cancer Trial in Detroit, New York (Cabozantinib)

Recruiting
  • Prostate Cancer
  • Detroit, Michigan
  • +2 more
Mar 30, 2022

Prostate Cancer Trial in Boston (ARN-509, Abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    (unnamed)
Jan 17, 2023

Prostate Cancer, Metastatic Castrate-Resistant Prostate Cancer, PSA Trial in Canada, United States (OGX-427, Abiraterone

Terminated
Has Results
  • Prostate Cancer
  • +2 more
  • Marina Del Rey, California
  • +15 more
Jul 7, 2022

Metastatic Prostate Cancer Trial in Perth (177Lu-DOTA-rosopatamb)

Not yet recruiting
  • Metastatic Prostate Cancer
  • 177Lu-DOTA-rosopatamb
  • (no location specified)
Aug 29, 2022

Prostatic Tumors, Castration-Resistant Trial in United States (64Cu-SAR-bisPSMA, 67Cu-SAR-bisPSMA)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Phoenix, Arizona
  • +6 more
May 23, 2022

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,

Recruiting
  • Prostate Cancer
  • +5 more
  • 177Lu-rhPSMA-10.1 injection
  • 18F-rhPSMA-7.3 injection
  • Glen Burnie, Maryland
  • +3 more
Feb 2, 2023

Prostate Carcinoma, Castration-resistant Prostate Cancer, Circulating Tumor Cells Trial in France (Cabazitaxel, Docetaxel)

Completed
  • Prostate Carcinoma
  • +3 more
  • Angers, France
  • +4 more
Feb 9, 2022

ARv7 in Plasma of Advanced Metastatic Castrate Resistant

Active, not recruiting
  • Metastatic Castrate Resistant Prostate Cancer
    • New Haven, Connecticut
      Yale University School of Medicine
    Sep 29, 2021

    Prostate Cancer Trial in Sapporo city, Kanazawa-city (177Lu-PSMA-617, 68Ga-PSMA-11, Best supportive/best standard of care)

    Recruiting
    • Prostate Cancer
    • 177Lu-PSMA-617
    • +2 more
    • Kashiwa, Chiba, Japan
    • +6 more
    Jan 23, 2023

    Metastatic Castrate- Resistant Prostate Cancer Trial in St Leonards (idronoxil (NOX66) suppository, Stereotactic Body Radiation

    Terminated
    • Metastatic Castrate- Resistant Prostate Cancer
    • idronoxil (NOX66) suppository
    • Stereotactic Body Radiation Therapy
    • St Leonards, New South Wales, Australia
      Royal North Shore Hospital
    May 9, 2022

    Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco

    Not yet recruiting
    • Castrate Resistant Prostate Cancer
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    Mar 1, 2023

    Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United

    Recruiting
    • Hormone-Resistant Prostate Cancer
    • +3 more
    • Ann Arbor, Michigan
    • +3 more
    Feb 2, 2023

    Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo

    Recruiting
    • Castration-Resistant Prostate Carcinoma
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 27, 2022

    Patients and Other Factors Which May Contribute to Survival

    Completed
    • Metastatic Castration Resistant Prostate Cancer (mCRPC)
    • Radium-223 dichloride (Xofigo, BAY88-8223)
    • Whippany, New Jersey
      Bayer Flatiron Xofigo Registry database
    Mar 17, 2022